SUZHOU, China, and HILDEN, Germany, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and SIP Biotech Development Co., Ltd. (BioBAY) today announced the opening of QIAGEN (Suzhou) Translational Medicine Center, a translational medicine R&D Corporation which aims to accelerate the discovery and validation of biomarkers, and to create companion diagnostics for the Chinese market. […]
DANVERS, MASS. – The BRAF assay from Beckman Coulter Genomics has been granted clinical laboratory licenses in four states, expanding the availability of the offering that last year received CLIA Certificates of Registration and Compliance. Pennsylvania, Maryland and Rhode Island, three of the seven states that require statewide licensure in addition to CLIA certificates, have […]
BEDFORD, Mass., — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic’s […]
ALAMEDA, CA.– Singulex, Inc., a privately held commercial-stage company committed to improving patient care and enabling the reduction of healthcare costs by providing high-value, advanced tests and systems for the diagnosis and monitoring of chronic diseases, today announced that Guido Baechler has been appointed President and Chief Executive Officer of the company effective immediately. Baechler, […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems™ 3500 Dx and 3500xL Dx Genetic Analyzers have been approved by the Federal Commission for Protection against Health Risks in Mexico for diagnostic use. The development marks a major extension of Life Technologies’ capabilities to serve the clinical end market inNorth […]
AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe. Meeting regulatory requirements to obtain the CE-IVDD mark for the new AB SCIEX API 3200MD™ and 3200MD QTRAP® LC/MS/MS systems* will provide European hospitals and clinical diagnostic laboratories the confidence […]
SEATTLE – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares to be sold and the price range […]
A research programme that will lay the foundations for anyone with cancer to have access to genetic testing has been launched with £2.7 million funding from the Wellcome Trust. Led by a team at The Institute of Cancer Research, London, in collaboration with The Royal Marsden, the Wellcome Trust Centre for Human Genetics and Illumina, […]
Madrid/Heidelberg,– Spanish-German biotech company SYGNIS Pharma AG (Frankfurt: LIO1; ISIN: DE000A1RFM03, Prime Standard segment of the German Stock Exchange) has signed a licence agreement for the distribution of a new amplification buffer with QIAGEN, the global leader in sample and assays technologies. This is the second agreement with QIAGEN within 9 months and the first […]
OMAHA, Neb. — Transgenomic, Inc. (OTCBB: TBIO) today announced the global, commercial availability of CRC RAScan™, a new mutation detection test to screen patients with metastatic colorectal cancer (mCRC) for RAS mutations (KRAS and NRAS). These RAS mutations, identified using the CRC RAScan™ kits which use Surveyor®-Wave® technology, provide physicians with important information regarding tumor […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
